Vinorelbine Tartrate Injection
Sponsors
RemeGen Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd, Shanghai Yizhong Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Advanced MalignanciesBreast CancerMetastatic Breast CancerMetastatic Breast Cancer (MBC)Recurrent Breast CancerTriple Negative Breast Cancer
Phase 1
Phase 3
A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2
NCT04400695
Start: 2020-09-29End: 2024-12-30Target: 366Updated: 2024-01-24
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
RecruitingNCT06079983
Start: 2023-12-01End: 2029-03-01Target: 400Updated: 2025-09-12
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
RecruitingNCT06143553
Start: 2023-09-25End: 2025-12-31Target: 168Updated: 2024-11-29
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
RecruitingNCT07533123
Start: 2026-03-17End: 2030-03-17Target: 364Updated: 2026-04-16